Projects per year
Personal profile
Biography
Graduated from the University of Cambridge in 2012 including an intercalated degree in Pharmacology (1st). He then undertook a Respiratroy Academic Foundation Job affiliated with the University of East Anglia and NHS Norfolk and Norwich. During these 2 years he obtained his MRCP(UK).
Following his Foundation Years, Mark worked for a year in Canberra, Australia. He obtained registration with the Australian Medical Council and retains registration. He returned to Scotland to undertake Core Medical Training, including a rotation at the Beatson West of Scotland Cancer Centre.
He began Specialty training in Medical Oncology in 2017 before taking up a SCREDS Clinical Lectureship with Prof Petty at the University of Dundee. He obtained CSO funding to undertake a 3 year PhD focussed on frailty in advanced gastroesophageal cancer and began this in August 2020.
Research
CSO Clinical Academic Fellow
Chair of NOTCH (National Oncology Trainee Collaborative for Healthcare Research)
Research interests
Frailty in advanced cancer
Biomarkers for chemosensitivity
Supportive care
Quality of life
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Medicine, Identifying and validating predictive Biomarkers in advanced oEsophageal adenocarcinoma – a springboard to REAListic medicine (BE-REAL), University of Dundee
Award Date: 6 Oct 2023
PGCert THE, Medical Education, University of Dundee
Award Date: 1 May 2018
Doctor of Medicine, MB BChir, University of Cambridge
Award Date: 27 Jun 2012
Bachelor of Arts, Pharmacology, University of Cambridge
1 Oct 2006 → 30 Jun 2009
Award Date: 30 Jun 2009
External positions
Medical Oncology Registrar, NHS Tayside
10 Sept 2018 → …
Keywords
- RC0254 Neoplasms. Tumors. Oncology (including Cancer)
- Frailty
- Geriatric Oncology
- Toxicity
- Gastric cancer
- Oesophageal cancer
Fingerprint
Dive into the research topics where Mark Baxter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Multimorbidity, Frailty And An Ageing Cancer Population – Using Health Data To Improve Decision Making
Baxter, M. (Investigator), Lang, C. (Investigator) & Petty, R. (Investigator)
1/01/25 → 31/12/27
Project: Research
-
Epidermal Growth Factor Receptor (EGFR) and The Tumour Microenvironment - Improving Outcomes With Immunotherapy in Patients with Gastroesophageal Adenocarcinoma
Baxter, M. (Investigator), Petty, R. (Investigator) & Spender, L. (Investigator)
1/02/24 → 31/01/26
Project: Research
-
Establishing Predictors Of Response To Chemotherapy In Advanced Gastroesophageal Adenocarcinoma - PostHoc Analysis Of The GO2 Trial
Baxter, M. (Investigator) & Petty, R. (Investigator)
1/01/23 → 30/09/24
Project: Research
-
Identifying and Validating Predictive Biomarkers in Advanced Oesophagael Adenocarcinoma - A Springboard to REAListic Medicine (BE-REAL)
Baxter, M. (Investigator)
1/10/20 → 29/02/24
Project: Research
-
Establishing DNA Damage Response-Deficient (DDRD) Status in Patients with Advanced Oesophageal Adenocarcinoma who have had an Exceptional Response to First Line Chemotherapy
Baxter, M. (Investigator), Petty, R. (Investigator) & Walsh, S. (Investigator)
1/03/19 → 31/08/19
Project: Research
-
AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma
Spender, L. C., Watt, D. M., Baxter, M. A., Shuttleworth, M. K., Walker, K., Savage, A. R., Clements, H. A., Kapelyukh, Y., Bray, S. E., King, S. I., Wolf, C. R., Inman, G. J., Walsh, S. V., Blyth, K. & Petty, R. D. (Lead / Corresponding author), 21 Sept 2025, In: British Journal of Cancer. 133, 5, p. 709-722 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile37 Downloads (Pure) -
Gastric Cancer
Mathews, M., Shareef, H., Baxter, M. A. & Petty, R. D., 2025, Treatment of Cancer. Price, P. & Sikora, K. (eds.). 8th ed. Boca Raton: CRC Press, p. 200-212 13 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter (peer-reviewed) › peer-review
-
KERMIT: Performance indicators in electronic patient reported outcome measures: a modified Delphi
Hatton, N. L. (Lead / Corresponding author), Baxter, M., Lewis, S., Hall, P. S. & Spencer, K., 2 Jul 2025, In: Journal of Patient-Reported Outcomes. 9, 7 p., 81.Research output: Contribution to journal › Article › peer-review
Open AccessFile14 Downloads (Pure) -
N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP)—A Prognostic Biomarker in Older and/or Frail Adults with Advanced Gastroesophageal Cancer: a post-hoc analysis of the GO2 clinical trial
Tao, Y., Lang, C., Petty, R., Hall, P. S. & Baxter, M. A. (Lead / Corresponding author), 10 Feb 2025, In: Cancers. 17, 4, 10 p., 601.Research output: Contribution to journal › Article › peer-review
Open AccessFile35 Downloads (Pure) -
Patient-Reported Outcomes in Geriatric Oncology-Balancing Quality of Life and Therapeutic Effectiveness Using Primary Breast Cancer as a Model
Francis, J., Baxter, M., Giza, D., Cheung, K.-L. & Parks, R. (Lead / Corresponding author), Jan 2025, In: Drugs & Aging. 42, 1, p. 1-7 7 p., e38301.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Activities
- 1 Invited talk
-
Is cancer biology in older persons different?
Baxter, M. (Speaker)
10 Nov 2023Activity: Talk or presentation types › Invited talk